ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons

Kuhn, Peer‐Hendrik, Wang, Huanhuan, Dislich, Bastian, Colombo, Alessio, Zeitschel, Ulrike, Ellwart, Joachim W, Kremmer, Elisabeth, Roßner, Steffen +1 more·2010·The EMBO Journal
DOI 10.1038/emboj.2010.167

Cited by (624)

Items 501–600 of 624

  1. Alzheimer’s Disease: Causes, Mechanisms, and Steps Toward Prevention
    Se Hoon Choi, Rudolph E. Tanzi · 2020 · Oxford University Press eBooks
  2. Signal peptide peptidase– and SPP-like 3–dependent shedding of α1,6-fucosyltransferase differentially affects core fucosylation
    Seita Tomida, Rebeca Kawahara, Kristina Mae Bienes · 2026 · Journal of Biological Chemistry
  3. Exploring Gene Expression Patterns in Alzheimer’s Disease Using a Human Microarray Data Meta-Analysis
    Eleni Dermitzaki, Vasileios L. Zogopoulos, Apostolos Malatras, Vasiliki Georgopoulou, Petrina-Marina Aslanoglou, Adamantia Teta, Maria Rea Kalligianni, Christos Karoussiotis, Vassiliki A. Iconomidou, Ioannis Sotiropoulos et al. · 2026 · Biology
  4. APP as an innate injury-response molecule
    Zachary T. Olmsted, Michael V. Sofroniew · 2026 · Neurobiology of Disease
  5. Single-cell analysis of Powassan virus-infected brains reveals age-dependent neuroinflammatory crosstalk and progressive Alzheimer’s-like APP/Aβ accumulation
    Marcos Romario Matos de Souza, Marissa R. Lindner, Megan C. Mladinich, Elena E. Gorbunova, Varvara Kirillov, Aisling G. Byrne, Autumn Y. Laird, Catherine E. Finnerty, Priscila Ikeda, Charles Kyriakos Vorkas et al. · 2026 · mBio
  6. Genetic and Epigenetic Architecture of Alzheimer’s Dementia
    Laura Cervera‐Carles, Jordi Clarimón · 2016 · Current Genetic Medicine Reports
  7. Alpha-secretase inhibition impairs Group I metabotropic glutamate receptor-mediated protein synthesis, long-term potentiation and long-term depression
    Bruce G. Mockett, James W. T. Davies, Zoe Mills, Do Yeong Kweon, Wickliffe C. Abraham · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
  8. Human Diseases Associated with Notch Signalling: Lessons from Drosophila melanogaster
    Marvel Megaly, Anel Turgambayeva, Ryan Douglas Hallam, Gregory Foran, Mark Megaly, Aleksandar Necakov · 2024 · Frontiers in Bioscience-Landmark
  9. Generation and characterization of the adult neuron-specific ADAM10 knock-out mice
    Jun Liu, Changwen Zhou, Qiulan Wei · 2012 · Hereditas (Beijing)
  10. Extracellular RNA in Alzheimer’s disease
    David A. Hicks · 2021 · ExRNA
  11. Amyloid Beta
    Abhinav Anand, Neha Sharma, Monica Gulati, Navneet Khurana · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  12. Structural Basis for Selective Proteolysis of ADAM10 Substrates at Membrane-Proximal Sites
    Colin H. Lipper, Emily D. Egan, Khal-Hentz Gabriel, Stephen C. Blacklow · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Amyloid Beta Hypothesis: Attention to β- and γ-Secretase Modulators
    Jan Korábečný, Katarína Špilovská, Ondřej Soukup, Rafael Doležal, Kamil Kuča · 2018 · InTech eBooks
  14. Transcriptional and post-transcriptional responses to amyloid- β in cerebral amyloid angiopathy
    Barend W. Florijn, Niek A. Verwey, Ellis S. van Etten, Helga E. de Vries, Marieke J.H. Wermer · 2025 · Journal of Cerebral Blood Flow & Metabolism
  15. Monocolonization with Bacteroides thetaiotaomicron exerts region-specific effects on Alzheimer’s disease-related traits in the murine brain
    Vu Thu Thuy Nguyen, Svenja König, Henning Formes, Zukaa Al Taleb, Florian Steinert, Bernd Bufe, Simone Eggert, Simone Stegmüller, Yannik Schermer, Elke Richling et al. · 2026 · Microbiology Spectrum
  16. A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairment
    Gillian A McNaugher, Leah McColgan, Mia Church, Paula L. McClean, David S. Gibson, Elaine K. Murray, Sophie Coyle, Victoria McGilligan · 2026 · Journal of Alzheimer s Disease
  17. Is Detection of Preclinical Alzheimer’s Disease Possible?
    Shana Brawer · 2018 · Touro Scholar (Touro College)
  18. ADAM10, Myelin-associated Metalloendopeptidase
    Rolf Postina, Falk Fahrenholz · 2012 · Handbook of Proteolytic Enzymes
  19. Cell-free protein production of a gamma secretase homolog
    Céline Moser, Claudia Muhle‐Goll · 2023 · Protein Expression and Purification
  20. ADAM10 Expression by Ameloblasts Is Essential for Proper Enamel Formation
    Shifa Shahid, Yuanyuan Hu, Fatma F. Mohamed · 2024 · International Journal of Molecular Sciences
  21. ADAM10: α-secretase in Alzheimer’s disease and regulator of neurobiology
    Paul Säftig, Johannes Prox · 2014 · e-Neuroforum
  22. An Alternate View of Neuroprotection with Peptides in Alzheimer’s Disease
    Samuel Peter King, Cenk Suphioglu · 2020 · IntechOpen eBooks
  23. [Proteolytic cleavage of neuroligins and functions of their cleavage products].
    Jie Yu, Junyu Xu · 2020 · PubMed Central
  24. 3’-O-Acetyl-24-Epi-7,8-Didehydrocimigenol-3-O-β-DXylopryranoside Decreases Amyloid Beta Production in Amyloid Precursor Protein-Transfected HeLa Cells
    Sang-Bin Lee, Ansun Park, Chi Thanh Ma · 2021 · Biomolecules & Therapeutics
  25. Structural Study of Membrane Glycoprotein-Precursor of β-Amyloid and Proteins Involved in Its Proteolysis
    Anatoly S. Urban, Yaroslav V. Bershatsky, Konstantin V. Pavlov, Eduard Valeryevich Bocharov · 2021 · Crystallography Reports
  26. Metalloproteases Meprin α and Meprin β in Health and Disease
    Claudia Tredup, Christoph Becker‐Pauly · 2015 · Elsevier eBooks
  27. Activators and Inhibitors of ADAM‐10 for Management of Cancer and Alzheimer's Disease
    Prajakta Kulkarni, Manas K. Haldar, Sanku Mallik · 2014
  28. Investigation of secreted amyloid precursor protein-α binding partners
    Simon McKenzie-Nickson · 2012 · Otago University Research Archive (University of Otago)
  29. ADAM10 mediates macroglial cell fate decisions in the developing brain
    Yihui Wang, Yue Liang, Daosheng Ai, Jun-Liszt Li, Ziyan Feng, Zhibao Guo, Xing-jun Chen, Tingting Zhang, Xiaoxiao Zou, Junli Gao et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  30. The Alzheimer disease continuum : findings from monogenic Alzheimer disease
    Charlotte Johansson · 2025
  31. α-Secretase processing of the Alzheimer amyloid-β precursor protein and its homolog APLP2
    Kristin T. Jacobsen · 2013 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  32. Meprin and ADAM Metalloproteases: Two Sides of the Same Coin?
    Christoph Becker‐Pauly, Stefan Rose‐John · 2015
  33. Cerebrospinal fluid biomarkers for differentiating between Alzheimer’s disease and Vascular dementia
    Maria Bjerke · 2011 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  34. Role of the 39-kDa receptor-associated protein (RAP) in Alzheimer's disease
    Hoang, T · 2012 · UTAS Research Repository
  35. Regulation of expression and cellular release of acetylcholinesterase
    David A. Hicks · 2013 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  36. Characterization of proteins involved in the production of β-Amyloid peptides and tau hyperphosphorlation in Familial Alzheimer’s Disease
    Barrera Ocampo, Álvaro Andrés · 2012
  37. Flavonoids as regulators of amyloid precursor protein processing
    Carla J. Cox · 2014 · The University of Bath Online Publications Store (The University of Bath)
  38. Struktur-Funktionsanalyse der BAR Domäne von Sorting Nexin 33
    Bastian Dislich · 2011 · DZNE Pub
  39. ADAM10: potential ‘molecular scissors‘ for the treatment of Alzheimer‘s disease
    Stefan F. Lichtenthaler · 2010 · Future Neurology
  40. The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
    Nevena Djogo · 2013
  41. Amyloid-β Protofibrils in Alzheimer´s Disease : Focus on Antibodies, Inflammation and Astrocytes
    Sofia Söllvander · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  42. Identification of ADAM10 5`UTR binding proteins - The RNA-binding protein Unr is involved in ADAM10 mRNA stability
    Christian Haass · 2014
  43. Future Pharmacological Armamentaria in Management of Alzheimer Disease
    Megha H Shah, Hetal D Shah, Vipul Chaudhari · 2013 · DOAJ (DOAJ: Directory of Open Access Journals)
  44. Application of Multivalent Displays on Metalloprotease-Dependent Cleavage of Semaphorin 4D in Synapse Development
    Frank A. Scangarello · 2012 · Brandeis Institutional Repository
  45. Dynamics of amyloid plaque formation in Alzheimer’s Disease
    Joanna F McCarter · 2014 · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München)
  46. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin b and ADAM10 Tamara JeffersonUlrich auf dem KellerCaroline BellacVerena V. MetzClaudia Broder • Jana HedrichAnke OhlerWladislaw MaierViktor MagdolenErwin Sterchi • Judith S. BondArumugam JayakumarHeiko TraupeAthena ChalarisStefan Rose-John • Claus U. PietrzikRolf PostinaChristopher M. OverallChristoph Becker-Pauly
    Johannes Gutenberg-University, Jana Hedrich, Anke Ohler · 2012
  47. Effects of DHA and EGCG on the alpha-secretase mediated processing of APP
    Hawmid Azizi · 2015 · The Atrium (University of Guelph)
  48. Alpha-synuclein expression influences the processing of the amyloid precursor protein
    Hazel Hall‐Roberts · 2016 · The University of Bath Online Publications Store (The University of Bath)
  49. Nitrate Chimeras: A New Class of Disease Modifying Agents for the Treatment of Alzheimer's Disease
    Lawren A. VandeVrede · 2014 · Figshare
  50. Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer's disease
    Emma Claire Phillips · 2017 · Research Portal (King's College London)
  51. Studies of amyloid precursor protein trafficking and processing
    Shaohua Xu · 2018 · Figshare
  52. The Regulation of Extracellular Amyloid-_ Levels by Ionotropic Glutamatergic Transmission in an Alzheimer
    Jane C. Hettinger · 2017 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  53. Alterations of synaptic plasticity and network functions in APP and APLP-deficient mice
    Ulrike Herrmann · 2015 · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG))
  54. Designing and preparation of new BACE1 inhibitors for Alzheimer's disease treatment
    Mariana Gomes Gonçalves Arelo Manso · 2019 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  55. Amyloid beta: from pre-analytical factors to disease mechanisms
    Jamie Toombs · 2019 · UCL Discovery (University College London)
  56. Mechanisms of neurodegeneration and potential rescue effects with respect to synaptic plasticity
    Leonie Salzburger · 2020 · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG))
  57. Implications of alpha- and beta-secretase expression and function in Alzheimer's disease
    Sven Reinhardt, K. Endres · 2020 · Elsevier eBooks
  58. Effects of anle138b treatment on amyloid-β neurotoxicity
    Carolina Thomas · 2020
  59. Genetic and functional studies of genes involved in the pathogenesis of Alzheimer's disease
    Teemu Natunen · 2014 · UEF eRepo (University of Eastern Finland)
  60. Genetic Association Between APP, ADAM10 Gene Polymorphism, and Sporadic Alzheimer's Disease in the Chinese Population
    Fan ZengCheng, LiuJing Li, Hua-Dong ZhouJuan · 2015
  61. Aluminum inhibits non-amyloid pathways via retinoic acid receptor
    Huan Li, Qun Liu, Liang Li, Xiujun Qin, Shanshan Wang, Jiali Hu, Xiaoting Lu, Jing Song, Nie Jisheng, Qinli Zhang et al. · 2021 · Journal of Trace Elements in Medicine and Biology
  62. Studies on the use of glycosaminoglycans for the treatment of Alzheimer's Disease
    Hao Cui · 2012 · UTAS Research Repository
  63. N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks
    Silvia Zampar · 2021
  64. Metalloproteases Meprin α and Meprin β in Health and Disease
    Franka Scharfenberg, Christoph Becker‐Pauly · 2022 · Elsevier eBooks
  65. Peer Review #1 of "Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats (v0.2)"
    2019 · PeerJ
  66. Amyloid Beta
    Abhinav Anand, Neha Sharma, Monica Gulati, Navneet Khurana · 2020 · IGI Global eBooks
  67. Faculty Opinions recommendation of Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.
    Paul Timpson · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  68. Peer Review #2 of "Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats (v0.1)"
    2019 · PeerJ
  69. Peer Review #1 of "Dendrobium alkaloids decrease Aβ by regulating α- and β-secretases in hippocampal neurons of SD rats (v0.1)"
    2019 · PeerJ
  70. ADAM10 pharmacological inhibition modifies the expression of components of the dopaminergic system
    Subhamita Maitra, Bruno Vincent · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  71. Does a rare mutation in PTPRA contribute to the development of Parkinson’s disease in an Australian multi-incident family?
    Melissa A. Hill, Steven R. Bentley, Tara L. Walker · 2022 · PLoS ONE
  72. The expression of the genes of presenilin 2 ADAM10 in Cynomolgus monkeys indicating amyloidopathy of Alzheimer’s type disease
    Huda Shalahudin Darusman, Lis Rosmanah, Sela Septima Mariya · 2023 · AIP conference proceedings
  73. A IMPORTÂNCIA DA REALIZAÇÃO DO ECOCARDIOGRAMA EM RN COM SÍNDROME DE DOWN PARA IDENTIFICAÇÃO PRECOCE DE CARDIOPATIAS CONGÊNITAS
    Murillo Henrique Azevedo da Silva, Lorran Ramos Gago, Marcele Nascimento Verdugo da Costa, Débora Sereno Peres, Victoria Telles de Lima Magalhães, Ana Carolina Suarez Polido, Amanda Maira de Melo Neves, Luana Machado Fonseca · 2023
  74. Is it possible to maintain a plaque-free healthy brain by treadmill?
    Swarupa Pahan, Kalipada Pahan · 2024 · Neural Regeneration Research
  75. Mechanism of synergistic enhancement of α-secretase (ADAM10) activity by EGCG and FA
    Yvning Guan, Wen Xu, Hongqi Ai · 2025 · ChemPhysMater
  76. ADAM10, myelin-associated metalloendopeptidase
    Rolf Postina, Falk Fahrenholz · 2025 · Handbook of Proteolytic Enzymes
  77. Interplay between depressive symptoms and Alzheimer’s disease dementia: unraveling the potential roles of ADAM10 and Negr1
    Danilo Barroso de Sousa, Maria Clara Ribeiro Zucato, Heloísa Máximo Ribeiro, Vanessa Alexandre-Silva, Márcia R. Cominetti · 2025 · Neuroscience
  78. NLGN3 contributes to angiogenesis in myocardial infarction via activation of the Gαi1/3-Akt pathway
    Shunsong Qiao, Chao Tang, Dejin Zhan · 2025 · Basic Research in Cardiology
  79. Detection of the Alzheimer's disease soluble amyloid precursor protein and modulation of its proteolytic processing
    Taverna, Mara · 2014 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  80. Additional file 5 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare
  81. Additional file 3 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare
  82. Additional file 1 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Zhou, Libing et al. · 2024 · Figshare
  83. Additional file 4 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Libing Zhou et al. · 2024 · Figshare
  84. Additional file 2 of Dysregulated expression of miR-140 and miR-122 compromised microglial chemotaxis and led to reduced restriction of AD pathology
    Chao Song, Li, Shufang, Mai, Yingren, Li, Linpeng, Guoku Dai, Zhou, Yuan, Xiaosheng Liang, Olivia Meilan Zou, Wang, Ya, Zhou, Libing et al. · 2024 · Figshare
  85. Emerging therapeutics and future insights into the pathobiology of Alzheimer’s disease
    Sang-Kyung Lee Irfan Ullah · 2018 · International Journal of Biosciences (IJB)
  86. Investigating the effects of post-exercise serum treatments on APP processing in iPSC-derived neurons and astrocytes
    Richard J. Elsworthy, Felicity S. E. Spencer, S. Allen, Connor Dunleavy, Martin Whitham, Samuel J.E. Lucas, Eric James Hill, Sarah Aldred · 2026 · The International Journal of Biochemistry & Cell Biology
  87. Expression of amyloid-β antibody via AAV of CNS tropism alleviates Alzheimer’s disease in mice
    Zhong‐Min Dai, Min Jiang, Wenqing Yin, Zhounan Wang, Xiaojing Zhu, Mengsheng S. Qiu · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
    Geoffroy O. Laumet · 2010 · theses.fr (ABES)
  89. Implication du complexe récepteur 5-HT4/APP/ADAM10 dans la voie non-amyloïdogénique de la maladie d’Alzheimer
    Maud Cochet · 2011 · theses.fr (ABES)
  90. Validation préclinique de l'efficacité de l'ANAVEX2-73 dans des modèles transgénique et non transgénique de la maladie d'Alzheimer
    Valentine Lahmy · 2014 · theses.fr (ABES)
  91. Etude du complexe récepteur 5-HT4/ADAM10/APP et recherche de protéines associées à l’ADAM10 : de nouveaux acteurs favorisant la voie non-amyloïdogénique dans le contexte de la maladie d'Alzheimer
    Romain Donneger · 2014 · theses.fr (ABES)
  92. Métalloprotéases matricielles et maladie d'Alzheimer : étude du rôle de MT1-MMP dans le métabolisme de l'APP/Aß
    Nathalie A. Py · 2014 · theses.fr (ABES)
  93. Etudes de trois métalloprotéases matricielles, MT1-MMP, MT5-MMP et MMP-12 dans l'amyloïdogenèse et les atteintes inflammatoires et vasculaires associées à la maladie d'Alzheimer
    Amandine Bonnet · 2017 · theses.fr (ABES)
  94. Mobilisation de l'acide arachidonique et sensibilité au peptide ß-amyloïde
    Mélanie H. Thomas · 2015 · theses.fr (ABES)
  95. Clustering hinders APP α-secretase processing in the plasma membrane
    Kerstin Pinkwart, Thorsten Lang · 2026 · Biophysical Journal
  96. Effets de la citrulline sur des modèles physiopathologiques de vieillissement cérébral et de maladie d'Alzheimer
    Antonin Ginguay · 2018 · theses.fr (ABES)
  97. Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer
    Laura Auboyer · 2018 · theses.fr (ABES)
  98. Effets des acides gras ω-3 sur l'inflammation cérébro-vasculaire associée à la maladie d'Alzheimer et aux angiopathies amyloïdes cérébrales
    Justine Hur · 2017 · theses.fr (ABES)
  99. Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
    Laura García‐González · 2020 · theses.fr (ABES)
  100. Métalloprotéases matricielles et maladie d'Alzheimer : étude des rôles de MT1- et MT5-MMP dans l'amyloïdogenèse et la neuro-inflammation
    Jean‐Michel Paumier · 2018 · theses.fr (ABES)